Dishman Carbogen Amcis

Last updated

Dishman Carbogen Amcis Limited
Company type Public
Industry Pharmaceuticals
Founded1983
Headquarters Ahmedabad, Gujarat, India [1]
Key people
  • Janmejay R. Vyas (Chairman & Managing Director)
  • Arpit J. Vyas (Global CFO)
  • Himani Dhotre (CEO)
ProductsBulk Drugs, Chemicals
RevenueIncrease2.svg2,440 crore (US$290 million) (FY23) [2]
Decrease2.svg−29 crore (US$−3.5 million) (FY23) [2]
Website www.imdcal.com

Dishman Carbogen Amcis Ltd is an Indian multinational pharmaceutical company specialized in the manufacture of active ingredients and contract development and manufacturing. Dishman employs over 1,000 people worldwide and is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE).

Contents

History

The Dishman Group was founded in 1983 by Shri Janmejay R. Vyas, Managing Director of the Dishman Group. Since the beginning, the focus of the Dishman Group has been on research and development of various in-house technologies for the manufacture of quaternary ammonium compounds (quats) and active pharmaceutical ingredients. The first facility of the Dishman Group was built in 1987 in Naroda; in 1996 the company initiated its expansion at Bavla where it is currently headquartered. Through several acquisitions, [3] the Dishman Group became a global company with multiple manufacturing facilities in India, Europe and China serving pharmaceutical and biopharmaceutical companies.

Company Structure

The Dishman Carbogen Amcis Group operates in two segments: contract research services and marketable molecules such as bulk drugs, intermediates, quaternary ammonium compounds (quats), specialty chemicals and phase transfer catalysts. Dishman operates in four business units:

Locations

Related Research Articles

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

Naroda is a fast-growing area in Ahmedabad, northeast of central Ahmedabad in the Indian state of Gujarat.

<span class="mw-page-title-main">Fine chemical</span> Pure chemical substances produced by and for the chemical industry

In chemistry, fine chemicals are complex, single, pure chemical substances, produced in limited quantities in multipurpose plants by multistep batch chemical or biotechnological processes. They are described by exacting specifications, used for further processing within the chemical industry and sold for more than $10/kg. The class of fine chemicals is subdivided either on the basis of the added value, or the type of business transaction, namely standard or exclusive products.

<span class="mw-page-title-main">Cambrex Corporation</span> American pharmaceutical company

Cambrex Corporation is a Contract Development Manufacturing Organisation (CDMO) that provides drug substance, drug product and analytical services across the entire drug lifecycle, as well as active pharmaceutical ingredients (APIs). With over 2,200 employees in 7 countries across 13 locations, Cambrex operates in branded and generic markets for API and dosage form development and manufacturing.

<span class="mw-page-title-main">Lonza Group</span> Swiss pharmaceutical and biotech company

Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector.

<span class="mw-page-title-main">Patheon</span>

Patheon is a service brand within Thermo Fisher Scientific's brand portfolio. Contract development and manufacturing organization (CDMO) services offered under the Patheon brand include small molecule API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics and commercial manufacturing and packaging. In 2017, Patheon was acquired by Thermo Fisher Scientific to form its Pharma Services business.

<span class="mw-page-title-main">Sun Pharma</span> Indian multinational pharmaceutical company

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. 

JSC Olpha is a Latvian leading manufacturer in the chemical and pharmaceutical sector of the Baltic States.

<span class="mw-page-title-main">Vivimed Labs</span>

Vivimed Labs Limited is an India-based global supplier of specialty chemicals and pharmaceuticals. Headquartered in Hyderabad, India. Vivimed is a manufacturer of active pharmaceutical ingredients, active ingredients for home and personal care, hair dyes, imaging chemicals and photochromics.

Unichem Laboratories is an Indian pharmaceutical company, headquartered in Mumbai. It manufactures and markets pharmaceutical formulations across the globe, including the regulated markets of the USA and Europe.

<span class="mw-page-title-main">Grindeks</span> Company based in Riga, Latvia

JSC Grindex, or simply Grindeks, is an internationally operating Latvian pharmaceutical company with headquarters in Riga, Latvia. Its portfolio consists of original products, generics, and active pharmaceutical ingredients. It mostly focuses on cardiovascular, central nervous system, anti-cancer, and diabetes medicines. Grindex is the leading pharmaceutical manufacturer in the Baltic States. In 2021, Grindex imported products to more than 90 countries.

Orchid Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992, by Kailasam Raghavendra Rao, an alumnus of IIM Ahmedabad. As of 2007, it was among the top fortune 500 Indian companies by market capitalization.

Teva API is an international pharmaceutical company headquartered in Israel. Teva API is a stand-alone business unit of Teva Pharmaceutical Industries limited, the largest generic drug manufacturer in the world and one of the 15 largest pharmaceutical companies worldwide.

<span class="mw-page-title-main">Aurobindo Pharma</span> Indian multinational pharmaceutical company

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.

<span class="mw-page-title-main">MacFarlan Smith</span> Scottish pharmaceutical research company

MacFarlan Smith is a pharmaceutical manufacturing company based in Edinburgh, Scotland, founded in 1815. After its sale from Johnson Matthey in June 2022 to Altaris Capital Partners, Macfarlan Smith rebranded as Veranova. Veranova is a CDMO specialising in the development and manufacturing of specialist and complex active pharmaceutical ingredients, or APIs. It has facilities across Europe and North America.

<span class="mw-page-title-main">ABA Chemicals</span> Chinese chemical manufacturing company

ABA Chemicals, also known as Abachem, is a Chinese chemical manufacturing company headquartered in Taicang. The company was founded in 2006 as Suzhou ABA Chemicals, and is traded on the Shenzhen Stock Exchange as 300261.

Curia is a contract research and manufacturing organization that provides drug discovery, development, cGMP manufacturing and aseptic fill and finish to the pharmaceutical and biotechnology industries. Founded in 1991, Curia operates in the United States, Europe and Asia, with its headquarters located in Albany, New York. Curia has announced deals and collaborations with such companies as Pfizer Inc., Merck & Co., Eli Lilly and Company, Takeda, Genentech, Bristol-Myers Squibb Co. and GE.

Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara. It is involved in the manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.

<span class="mw-page-title-main">Laurus Labs</span> Indian pharmaceutical company

Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients (APIs), generic formulations, custom synthesis (CDMO), biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.

<span class="mw-page-title-main">Divi's Laboratories</span> Indian pharmaceutical company

Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.

References

  1. "DISHMAN PHARMACEUTICALS & CH (DISH:Natl India): Stock Quote & Company Profile - BusinessWeek". Investing.businessweek.com. Archived from the original on 18 January 2013. Retrieved 23 December 2011.
  2. 1 2 "Dishman Carbogen Amcis Ltd Q4 FY2023 consolidated loss at Rs. 70.72 crores". EquityBulls. 23 May 2023. Retrieved 24 June 2023.
  3. "East meets West". Archived from the original on 4 March 2016. Retrieved 28 June 2012.
  4. "Dishman Veenendaal". Archived from the original on 27 March 2018. Retrieved 26 July 2019.
  5. http://dishmancare.com/
  6. http://www.carbogen-amcis.com
  7. "Archived copy" (PDF). Archived from the original (PDF) on 26 May 2012. Retrieved 28 June 2012.{{cite web}}: CS1 maint: archived copy as title (link)
  8. http://www.pharmtech.com/pharmtech/Ingredients+Insider/CMOs-Invest-in-High-Potency-Manufacturing/ArticleStandard/Article/detail/534703 [ dead link ]
  9. "Archived copy" (PDF). Archived from the original (PDF) on 4 March 2016. Retrieved 28 June 2012.{{cite web}}: CS1 maint: archived copy as title (link)
  10. 1 2 "Dishman buys Swiss pharma major Carbogen". Business Standard India. 24 August 2006.
  11. CONTRACT, PHARMA. "Completes successful Swissmedic inspection at Vionnaz, Switzerland". Contract Pharma. Retrieved 10 June 2022.
  12. "Carbogen Amcis Acquires Creapharm Parenterals".
  13. "Indian CMO expands in Europe and Middle East".